Visx
This article was originally published in The Gray Sheet
Executive Summary
Is "hopeful" that a premarket approval application for its Twenty/Twenty excimer laser for phototherapeutic keratectomy will be reviewed at the next meeting of FDA's Ophthalmic Devices Panel, scheduled for March 21-22. Use of the excimer laser for PTK "was one subject discussed during a closed door session" of the panel last October, the company says in its third quarter 1993 report